These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 331818)
21. Multi-organ transplantation: is there a protective effect against acute and chronic rejection? Pinderski LJ; Kirklin JK; McGiffin D; Brown R; Naftel DC; Young KR; Smith K; Bourge RC; Tallaj JA; Rayburn BK; Benza R; Zorn G; Leon K; Wille K; Deierhoi M; George JF J Heart Lung Transplant; 2005 Nov; 24(11):1828-33. PubMed ID: 16297789 [TBL] [Abstract][Full Text] [Related]
22. Left ventricular dysfunction after heart transplantation: incidence and role of enhanced immunosuppression. McNamara D; Di Salvo T; Mathier M; Keck S; Semigran M; Dec GW J Heart Lung Transplant; 1996 May; 15(5):506-15. PubMed ID: 8771506 [TBL] [Abstract][Full Text] [Related]
23. Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3. Kirklin JK; Bourge RC; White-Williams C; Naftel DC; Thomas FT; Thomas JM; Phillips MG J Thorac Cardiovasc Surg; 1990 Apr; 99(4):716-24. PubMed ID: 2108282 [TBL] [Abstract][Full Text] [Related]
24. Current state of heart transplantation. McGregor CG Br J Hosp Med; 1987 Apr; 37(4):310-3, 316-8. PubMed ID: 3107643 [TBL] [Abstract][Full Text] [Related]
34. Echocardiography-guided endomyocardial biopsy. A 5-year experience. Miller LW; Labovitz AJ; McBride LA; Pennington DG; Kanter K Circulation; 1988 Nov; 78(5 Pt 2):III99-102. PubMed ID: 3052923 [TBL] [Abstract][Full Text] [Related]
35. OKT3 treatment of cardiac allograft rejection. Haverty TP; Sanders M; Sheahan M J Heart Lung Transplant; 1993; 12(4):591-8. PubMed ID: 8369321 [TBL] [Abstract][Full Text] [Related]
36. The University of California at Los Angeles heart transplantation experience. Kobashigawa JA; Laks H; Wu G; Patel J; Moriguchi J; Hamilton M; Fonarow G; Fishbein M; Ardehali A Clin Transpl; 2005; ():173-85. PubMed ID: 17424734 [TBL] [Abstract][Full Text] [Related]
37. The status of cardiac transplantation, 1975. Rider AK; Copeland JG; Hunt SA; Mason J; Specter MJ; Winkle RA; Bieber CP; Billingham ME; Dong E; Griepp RB; Schroeder JS; Stinson EB; Harrison DC; Shumway NE Circulation; 1975 Oct; 52(4):531-9. PubMed ID: 1098809 [TBL] [Abstract][Full Text] [Related]
38. [Pathology of heart transplantation.(Morphological study of 1246 endomyocardial biopsies from 167 transplanted hearts). Causes of early, intermediate, and late deaths]. Agozzino L; Thomopoulos K; Esposito S; Agozzino M; De Vivo F; Maiello C; Cotrufo M Pathologica; 1999 Apr; 91(2):89-100. PubMed ID: 10484868 [TBL] [Abstract][Full Text] [Related]
39. Role of routine endomyocardial biopsy to monitor late rejection after heart transplantation. Spratt P; Sivathasan C; Macdonald P; Keogh A; Chang V J Heart Lung Transplant; 1991; 10(6):912-4. PubMed ID: 1756155 [TBL] [Abstract][Full Text] [Related]
40. Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection. Potena L; Holweg CT; Chin C; Luikart H; Weisshaar D; Narasimhan B; Fearon WF; Lewis DB; Cooke JP; Mocarski ES; Valantine HA Transplantation; 2006 Aug; 82(3):398-405. PubMed ID: 16906040 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]